To evaluate the relationship between the three-gene CRG biosignature developed above and the relative immune cell infiltration of the tumor microenvironment in CRBC patients, we next utilized the CIBERSOFT algorithm to compare high- and low-risk patient immune cell infiltration (Figure 8(b)). This evidence concerns the gene CHD7 and neoplasm.